Creation of a prevascularized site for cell transplantation in rats

Xenotransplantation

Volumn 17, Issue 5, 2010, Pages 379-390

  Stiegler, Philipp ^a   Matzi, Veronika ^a   Pierer, Eve ^a   Hauser, Oliver ^b   Schaffellner, Silvia ^a   Renner, Heiko ^a   Greilberger, Joachim ^a   Aigner, Reingard ^a   Maier, Alfred ^a   Lackner, Carolin ^a   Iberer, Florian ^a   Smolle Jüttner, Freyja Maria ^a   Tscheliessnigg, Karlheinz ^a   Stadlbauer, Vanessa ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b Ziel Biopharma Ltd   (Ireland)

Author keywords

angiogenesis; HEK293; hyperbaric oxygenation; islet cells; microencapsulation; vacuum assisted wound closure; xenotransplantation

Indexed keywords

CELLULOSE SULFATE; SODIUM CELLULOSE SULPHATE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; BLOOD FLOW; CELL STRAIN HEK293; CELL TRANSPLANTATION; CONTROLLED STUDY; FOAM DRESSING; HYPERBARIC OXYGEN; MICROENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; VACUUM ASSISTED CLOSURE; VASCULARIZATION; XENOTRANSPLANTATION;

ANIMALS; CELL TRANSPLANTATION; DRUG COMPOUNDING; HEK293 CELLS; HUMANS; IMPLANTS, EXPERIMENTAL; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78349262770     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2010.00606.x     Document Type: Article

References (79)

1. Abalovich AG, Bacque MC, Grana D, Milei J,. Pig pancreatic islet transplantation into spontaneously diabetic dogs. Transplant Proc 2009; 41: 328-330.
2. Mackenzie DA, Hullett DA, Sollinger HW,. Xenogeneic transplantation of porcine islets: an overview. transplantation 2003; 76: 887-891.
3. Lim F, Sun AM,. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980; 210: 908-910.
4. Chang TM,. Semipermeable Microcapsules. Science 1964; 146: 524-525.
5. Chang TMS,. Artificial cells. Springfield, IL: Thomas, 1972.
6. Chang TMS,. Artificial cells: biotechnology, nanomedicine, regenerative medicine, blood substitutes, bioencapsulation, and cell/stem cell therapy. New Jersey: World Scientific, 2007.
7. Jansson L, Carlsson PO,. Graft vascular function after transplantation of pancreatic islets. Diabetologia 2002; 45: 749-763.
8. Johansson M, Olerud J, Jansson L, Carlsson PO,. Prolactin treatment improves engraftment and function of transplanted pancreatic islets. Endocrinology 2009; 150: 1646-1653.
9. Van Schilfgaarde R, De Vos P,. Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets. J Mol Med 1999; 77: 199-205.
10. Menger MD, Yamauchi J, Vollmar B,. Revascularization and microcirculation of freely grafted islets of Langerhans. World J Surg 2001; 25: 509-515.
11. De Vos P, Van Straaten JF, Nieuwenhuizen AG, et al. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes 1999; 48: 1381-1388.
12. Schrezenmeir J, Kirchgessner J, Gero L, Kunz LA, Beyer J, Mueller-Klieser W,. Effect of microencapsulation on oxygen distribution in islets organs. Transplantation 1994; 57: 1308-1314.
13. Wang W, Gu Y, Hori H, et al. Subcutaneous transplantation of macroencapsulated porcine pancreatic endocrine cells normalizes hyperglycemia in diabetic mice. Transplantation 2003; 76: 290-296.
14. Grundfest-Broniatowski SF, Tellioglu G, Rosenthal KS, et al. A new bioartificial pancreas utilizing amphiphilic membranes for the immunoisolation of porcine islets: a pilot study in the canine. ASAIO J 2009; 55: 400-405.
15. Hussey AJ, Winardi M, Han X, et al. Seeding of pancreatic islets into pre-vascularized tissue-engineering chambers. Tissue Eng Part A 2009; 15: 3823-3833.
16. Fort A, Fort N, Ricordi C, Stabler CL,. Biohybrid devices and encapsulation technologies for engineering a bioartificial pancreas. Cell Transplant 2008; 17: 997-1003.
17. Jia X, Cheng K, Mahato RI,. Coexpression of vascular endothelial growth factor and interleukin-1 receptor antagonist for improved human islet survival and function. Mol Pharm 2007; 4: 199-207.
18. Kim HA, Lee BW, Kang D, Kim JH, Ihm SH, Lee M,. Delivery of hypoxia-inducible VEGF gene to rat islets using polyethylenimine. J Drug Target 2009; 17: 1-9.
19. Kim SJ, Nian C, Doudet DJ, Mcintosh CH,. Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation. Diabetes 2009; 58: 641-651.
20. Stendahl JC, Wang LJ, Chow LW, Kaufman DB, Stupp SI,. Growth factor delivery from self-assembling nanofibers to facilitate islet transplantation. Transplantation 2008; 86: 478-481.
21. Langlois A, Bietiger W, Mandes K, et al. Overexpression of vascular endothelial growth factor in vitro using deferoxamine: a new drug to increase islet vascularization during transplantation. Transplant Proc 2008; 40: 473-476.
22. Olsson R, Carlsson PO,. The pancreatic islet endothelial cell: emerging roles in islet function and disease. Int J Biochem Cell Biol 2006; 38: 710-714. (Pubitemid 43363406)
23. Hara Y, Fujino M, Takeuchi M, Li XK,. Green-tea polyphenol (-)-epigallocatechin-3-gallate provides resistance to apoptosis in isolated islets. J Hepatobiliary Pancreat Surg 2007; 14: 493-497.
24. Linn T, Schmitz J, Hauck-Schmalenberger I, et al. Ischaemia is linked to inflammation and induction of angiogenesis in pancreatic islets. Clin Exp Immunol 2006; 144: 179-187.
25. Olsson R, Maxhuni A, Carlsson PO,. Revascularization of transplanted pancreatic islets following culture with stimulators of angiogenesis. Transplantation 2006; 82: 340-347.
26. Ijichi H, Taketomi A, Yoshizumi T, et al. Hyperbaric oxygen induces vascular endothelial growth factor and reduces liver injury in regenerating rat liver after partial hepatectomy. J Hepatol 2006; 45: 28-34.
27. Lee CC, Chen SC, Tsai SC, et al. Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical vein endothelial cells. J Biomed Sci 2006; 13: 143-156.
28. Eneroth M, Van Houtum WH,. The value of debridement and Vacuum-Assisted Closure (V.A.C.) Therapy in diabetic foot ulcers. Diabetes Metab Res Rev 2008; 24 Suppl.1: S76-S80.
29. Teramura Y, Iwata H,. Islet encapsulation with living cells for improvement of biocompatibility. Biomaterials 2009; 30: 2270-2275.
30. General Anaesthesia in adult rodents, SOP#2. University animal care commitee of McGill University.
31. Dautzenberg H, Schuldt U, Grasnick G, et al. Development of cellulose sulfate-based polyelectrolyte complex microcapsules for medical applications. Ann N Y Acad Sci 1999; 875: 46-63.
32. Lamprecht M, Greilberger J, Oettl K,. Analytical aspects of oxidatively modified substances in sports and exercises. Nutrition 2004; 20: 728-730.
33. De Vos P, De Haan BJ, De Haan A, Van Zanten J, Faas MM,. Factors influencing functional survival of microencapsulated islet grafts. Cell Transplant 2004; 13: 515-524.
34. Lohr M, Bago ZT, Bergmeister H, et al. Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study. J Mol Med 1999; 77: 393-398.
35. Lohr M, Hoffmeyer A, Kroger J, et al. Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma. Lancet 2001; 357: 1591-1592.
36. Lohr M, Hummel F, Faulmann G, et al. Microencapsulated, CYP2B1-transfected cells activating ifosfamide at the site of the tumor: the magic bullets of the 21st century. Cancer Chemother Pharmacol 2002; 49 Suppl 1: S21-S24.
37. Salmons B, Lohr M, Gunzburg WH,. Treatment of inoperable pancreatic carcinoma using a cell-based local chemotherapy: results of a phase I/II clinical trial. J Gastroenterol 2003; 38 (Suppl 15): 78-84.
38. Stadlbauer V, Stiegler PB, Schaffellner S, et al. Morphological and functional characterization of a pancreatic beta-cell line microencapsulated in sodium cellulose sulfate/poly(diallyldimethylammonium chloride). Xenotransplantation 2006; 13: 337-344.
39. Schaffellner S, Stadlbauer V, Stiegler P, et al. Porcine islet cells microencapsulated in sodium cellulose sulfate. Transplant Proc 2005; 37: 248-252.
40. Stiegler PB, Stadlbauer V, Schaffellner S, et al. Cryopreservation of insulin-producing cells microencapsulated in sodium cellulose sulfate. Transplant Proc 2006; 38: 3026-3030.
41. Stiegler P, Stadlbauer V, Schaffellner S, et al. Cryopreservation of freshly isolated porcine islet cells. Transplant Proc 2007; 39: 1609-1611.
42. De Vos P, Wolters GH, Fritschy WM, Van Schilfgaarde R,. Obstacles in the application of microencapsulation in islet transplantation. Int J Artif Organs 1993; 16: 205-212.
43. De Vos P, Vegter D, De Haan BJ, Strubbe JH, Bruggink JE, Van Schilfgaarde R,. Kinetics of intraperitoneally infused insulin in rats. Functional implications for the bioartificial pancreas. Diabetes 1996; 45: 1102-1107.
44. Ricordi C,. Pancreatic Islet Cell Transplantation. Austin, TX: Landes Company, 1992.
45. De Groot M, Schuurs TA, Van Schilfgaarde R,. Causes of limited survival of microencapsulated pancreatic islet grafts. J Surg Res 2004; 121: 141-150.
46. Avila JG, Wang Y, Barbaro B, et al. Improved outcomes in islet isolation and transplantation by the use of a novel hemoglobin-based O2 carrier. Am J Transplant 2006; 6: 2861-2870.
47. Hughes SJ, Davies SE, Powis SH, Press M,. Hyperoxia improves the survival of intraportally transplanted syngeneic pancreatic islets. Transplantation 2003; 75: 1954-1959.
48. Labler L, Rancan M, Mica L, Harter L, Mihic-Probst D, Keel M,. Vacuum-assisted closure therapy increases local interleukin-8 and vascular endothelial growth factor levels in traumatic wounds. J Trauma 2009; 66: 749-757.
49. Labanaris AP, Polykandriotis E, Horch RE,. The effect of vacuum-assisted closure on lymph vessels in chronic wounds. J Plast Reconstr Aesthet Surg 2009; 62: 1068-1075.
50. Fabian TS, Kaufman HJ, Lett ED, et al. The evaluation of subatmospheric pressure and hyperbaric oxygen in ischemic full-thickness wound healing. Am Surg 2000; 66: 1136-1143.
51. Riccio M, Paolo Pangrazi P, Campodonico A, Bertani A,. Delayed microsurgical reconstruction of the extremities for complex soft-tissue injuries. Microsurgery 2005; 25: 272-283.
52. Leung A, Trau M, Nielsen LK,. Assembly of multilayer PSS/PAH membrane on coherent alginate/PLO microcapsule for long-term graft transplantation. J Biomed Mater Res A 2009; 88: 226-237.
53. Webb LX,. New techniques in wound management: vacuum-assisted wound closure. J Am Acad Orthop Surg 2002; 10: 303-311.
54. Kidszun A, Schneider D, Erb D, et al. Isolated pancreatic islets in three-dimensional matrices are responsive to stimulators and inhibitors of angiogenesis. Cell Transplant 2006; 15: 489-497.
55. Cheng Y, Liu YF, Zhang JL, Li TM, Zhao N,. Elevation of vascular endothelial growth factor production and its effect on revascularization and function of graft islets in diabetic rats. World J Gastroenterol 2007; 13: 2862-2866.
56. Brissova M, Shostak A, Shiota M, et al. Pancreatic islet production of vascular endothelial growth factor-a is essential for islet vascularization, revascularization, and function. Diabetes 2006; 55: 2974-2985.
57. Ahmad Y,. SA. Effect of Hyperoxia on Vascular Endothelial Growth Factor Levels in a Wound Model. Arch Surg 2000; 135: 1293-1297.
58. Howdieshell TR, Riegner C, Gupta V, et al. Normoxic wound fluid contains high levels of vascular endothelial growth factor. Ann Surg 1998; 228: 707-715.
59. Lin S, Shyu KG, Lee CC, et al. Hyperbaric oxygen selectively induces angiopoietin-2 in human umbilical vein endothelial cells. Biochem Biophys Res Commun 2002; 296: 710-715.
60. Asano T, Kaneko E, Shinozaki S, et al. Hyperbaric oxygen induces basic fibroblast growth factor and hepatocyte growth factor expression, and enhances blood perfusion and muscle regeneration in mouse ischemic hind limbs. Circ J 2007; 71: 405-411.
61. Murray J, Oquendo CE, Willis JH, Marusich MF, Capaldi RA,. Monitoring oxidative and nitrative modification of cellular proteins; a paradigm for identifying key disease related markers of oxidative stress. Adv Drug Deliv Rev 2008; 60: 1497-1503.
62. Alamdari DH, Kostidou E, Paletas K, et al. High sensitivity enzyme-linked immunosorbent assay (ELISA) method for measuring protein carbonyl in samples with low amounts of protein. Free Radic Biol Med 2005; 39: 1362-1367.
63. Maisonneuve E, Fraysse L, Lignon S, Capron L, Dukan S,. Carbonylated proteins are detectable only in a degradation-resistant aggregate state in Escherichia coli. J Bacteriol 2008; 190: 6609-6614.
64. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A,. Protein carbonylation in human diseases. Trends Mol Med 2003; 9: 169-176.
65. Stolzing A, Grune T,. The proteasome and its function in the ageing process. Clin Exp Dermatol 2001; 26: 566-572. (Pubitemid 32989580)
66. Biernacki M, Bigda J, Jankowski K, Wozniak M, Sledzinski Z,. Increased serum levels of markers of oxidative stress during kidney transplantation. Transplant Proc 2002; 34: 544-545.
67. Rajesh M, Sulochana KN, Coral K, et al. Determination of carbonyl group content in plasma proteins as a useful marker to assess impairment in antioxidant defense in patients with Eales' disease. Indian J Ophthalmol 2004; 52: 139-144.
68. Narkowicz CK, Vial JH, Mccartney PW,. Hyperbaric oxygen therapy increases free radical levels in the blood of humans. Free Radic Res Commun 1993; 19: 71-80.
69. Rothfuss A, Merk O, Radermacher P, Speit G,. Evaluation of mutagenic effects of hyperbaric oxygen (HBO) in vitro II. Induction of oxidative DNA damage and mutations in the mouse lymphoma assay. Mutat Res 2000; 471: 87-94.
70. Dennog C, Radermacher P, Barnett YA, Speit G,. Antioxidant status in humans after exposure to hyperbaric oxygen. Mutat Res 1999; 428: 83-89.
71. Benedetti S, Lamorgese A, Piersantelli M, Pagliarani S, Benvenuti F, Canestrari F,. Oxidative stress and antioxidant status in patients undergoing prolonged exposure to hyperbaric oxygen. Clin Biochem 2004; 37: 312-317.
72. Eken A, Aydin A, Sayal A, Ustundag A, Duydu Y, Dundar K,. The effects of hyperbaric oxygen treatment on oxidative stress and SCE frequencies in humans. Clin Biochem 2005; 38: 1133-1137.
73. Rothfuss A, Dennog C, Speit G,. Adaptive protection against the induction of oxidative DNA damage after hyperbaric oxygen treatment. Carcinogenesis 1998; 19: 1913-1917.
74. Ozden TA, Uzun H, Bohloli M, et al. The effects of hyperbaric oxygen treatment on oxidant and antioxidants levels during liver regeneration in rats. Tohoku J Exp Med 2004; 203: 253-265.
75. Groger M, Oter S, Simkova V, et al. DNA damage after long-term repetitive hyperbaric oxygen exposure. J Appl Physiol 2009; 106: 311-315.
76. Speit G, Dennog C, Radermacher P, Rothfuss A,. Genotoxicity of hyperbaric oxygen. Mutat Res 2002; 512: 111-119.
77. Sander AL, Henrich D, Muth CM, Marzi I, Barker JH, Frank JM,. In vivo effect of hyperbaric oxygen on wound angiogenesis and epithelialization. Wound Repair Regen 2009; 17: 179-184.
78. Clark LA, Moon RE,. Hyperbaric oxygen in the treatment of life-threatening soft-tissue infections. Respir Care Clin N Am 1999; 5: 203-219.
79. Sakata N, Chan NK, Ostrowski RP, Chrisler J, Hayes P, Kim S, et al. Hyperbaric oxygen therapy improves early posttransplant islet function. Pediatr Diabetes.